nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—prostate cancer—urinary bladder cancer	0.402	1	CtDrD
Estradiol—ESR2—urinary bladder cancer	0.129	0.619	CbGaD
Estradiol—ESR1—urinary bladder cancer	0.0798	0.381	CbGaD
Estradiol—ABCC10—Gemcitabine—urinary bladder cancer	0.0287	0.122	CbGbCtD
Estradiol—ABCC10—Etoposide—urinary bladder cancer	0.0205	0.0871	CbGbCtD
Estradiol—ABCC10—Doxorubicin—urinary bladder cancer	0.014	0.0594	CbGbCtD
Estradiol—SLCO1C1—Methotrexate—urinary bladder cancer	0.0135	0.0575	CbGbCtD
Estradiol—ABCC10—Methotrexate—urinary bladder cancer	0.0135	0.0575	CbGbCtD
Estradiol—AOX1—Methotrexate—urinary bladder cancer	0.0128	0.0544	CbGbCtD
Estradiol—UGT1A1—Etoposide—urinary bladder cancer	0.00962	0.0409	CbGbCtD
Estradiol—ABCB1—Mitomycin—urinary bladder cancer	0.00928	0.0395	CbGbCtD
Estradiol—CYP1B1—Doxorubicin—urinary bladder cancer	0.00759	0.0323	CbGbCtD
Estradiol—SLCO1B3—Methotrexate—urinary bladder cancer	0.00755	0.0321	CbGbCtD
Estradiol—SLC22A2—Cisplatin—urinary bladder cancer	0.00729	0.031	CbGbCtD
Estradiol—SLC22A11—Methotrexate—urinary bladder cancer	0.00698	0.0297	CbGbCtD
Estradiol—ABCG2—Fluorouracil—urinary bladder cancer	0.00634	0.027	CbGbCtD
Estradiol—ABCG2—Carboplatin—urinary bladder cancer	0.0063	0.0268	CbGbCtD
Estradiol—ABCG2—Cisplatin—urinary bladder cancer	0.00538	0.0229	CbGbCtD
Estradiol—ABCG2—Etoposide—urinary bladder cancer	0.00529	0.0225	CbGbCtD
Estradiol—SLCO1A2—Methotrexate—urinary bladder cancer	0.00466	0.0198	CbGbCtD
Estradiol—SLCO1B1—Methotrexate—urinary bladder cancer	0.0044	0.0187	CbGbCtD
Estradiol—ALB—Fluorouracil—urinary bladder cancer	0.00437	0.0186	CbGbCtD
Estradiol—CYP3A4—Thiotepa—urinary bladder cancer	0.00422	0.0179	CbGbCtD
Estradiol—SLC22A8—Methotrexate—urinary bladder cancer	0.00406	0.0173	CbGbCtD
Estradiol—ABCG2—Doxorubicin—urinary bladder cancer	0.00361	0.0153	CbGbCtD
Estradiol—ABCG2—Methotrexate—urinary bladder cancer	0.0035	0.0149	CbGbCtD
Estradiol—CYP2C8—Fluorouracil—urinary bladder cancer	0.00338	0.0144	CbGbCtD
Estradiol—CYP3A5—Etoposide—urinary bladder cancer	0.00293	0.0125	CbGbCtD
Estradiol—CYP2C8—Etoposide—urinary bladder cancer	0.00282	0.012	CbGbCtD
Estradiol—ABCB1—Gemcitabine—urinary bladder cancer	0.00267	0.0114	CbGbCtD
Estradiol—CYP1A2—Fluorouracil—urinary bladder cancer	0.00261	0.0111	CbGbCtD
Estradiol—AR—scrotum—urinary bladder cancer	0.00241	0.0634	CbGeAlD
Estradiol—ALB—Methotrexate—urinary bladder cancer	0.00241	0.0102	CbGbCtD
Estradiol—CYP2C9—Fluorouracil—urinary bladder cancer	0.00236	0.01	CbGbCtD
Estradiol—CYP1A2—Etoposide—urinary bladder cancer	0.00218	0.00928	CbGbCtD
Estradiol—CYP2C9—Cisplatin—urinary bladder cancer	0.002	0.00851	CbGbCtD
Estradiol—ABCB1—Cisplatin—urinary bladder cancer	0.00194	0.00826	CbGbCtD
Estradiol—ABCB1—Etoposide—urinary bladder cancer	0.00191	0.00811	CbGbCtD
Estradiol—GPER1—prostate gland—urinary bladder cancer	0.00133	0.0351	CbGeAlD
Estradiol—ABCB1—Doxorubicin—urinary bladder cancer	0.0013	0.00553	CbGbCtD
Estradiol—ABCB1—Methotrexate—urinary bladder cancer	0.00126	0.00536	CbGbCtD
Estradiol—UGT1A1—urine—urinary bladder cancer	0.00124	0.0325	CbGeAlD
Estradiol—CYP3A4—Etoposide—urinary bladder cancer	0.00114	0.00486	CbGbCtD
Estradiol—AR—penis—urinary bladder cancer	0.00109	0.0286	CbGeAlD
Estradiol—FABP2—epithelium—urinary bladder cancer	0.00108	0.0284	CbGeAlD
Estradiol—ESRRB—female reproductive system—urinary bladder cancer	0.00106	0.0279	CbGeAlD
Estradiol—GPER1—smooth muscle tissue—urinary bladder cancer	0.000945	0.0248	CbGeAlD
Estradiol—SLC22A8—urine—urinary bladder cancer	0.0008	0.021	CbGeAlD
Estradiol—CYP3A4—Doxorubicin—urinary bladder cancer	0.000779	0.00331	CbGbCtD
Estradiol—GPER1—female reproductive system—urinary bladder cancer	0.000728	0.0191	CbGeAlD
Estradiol—CYP2C19—urine—urinary bladder cancer	0.00067	0.0176	CbGeAlD
Estradiol—GPER1—vagina—urinary bladder cancer	0.000659	0.0173	CbGeAlD
Estradiol—ESRRA—prostate gland—urinary bladder cancer	0.00062	0.0163	CbGeAlD
Estradiol—CYP1A2—urine—urinary bladder cancer	0.000548	0.0144	CbGeAlD
Estradiol—ESRRA—seminal vesicle—urinary bladder cancer	0.000525	0.0138	CbGeAlD
Estradiol—CYP2C9—urine—urinary bladder cancer	0.00052	0.0137	CbGeAlD
Estradiol—FABP2—lymph node—urinary bladder cancer	0.00047	0.0124	CbGeAlD
Estradiol—Fulvestrant—ESR2—urinary bladder cancer	0.000455	0.161	CrCbGaD
Estradiol—UGT1A1—prostate gland—urinary bladder cancer	0.000444	0.0117	CbGeAlD
Estradiol—GPER1—lymph node—urinary bladder cancer	0.000426	0.0112	CbGeAlD
Estradiol—ESRRA—renal system—urinary bladder cancer	0.000423	0.0111	CbGeAlD
Estradiol—SLCO4A1—prostate gland—urinary bladder cancer	0.00042	0.011	CbGeAlD
Estradiol—ESRRA—urethra—urinary bladder cancer	0.000415	0.0109	CbGeAlD
Estradiol—CYP3A4—urine—urinary bladder cancer	0.000396	0.0104	CbGeAlD
Estradiol—ESR2—prostate gland—urinary bladder cancer	0.000372	0.00979	CbGeAlD
Estradiol—SHBG—prostate gland—urinary bladder cancer	0.000362	0.00952	CbGeAlD
Estradiol—AOX1—prostate gland—urinary bladder cancer	0.000358	0.00942	CbGeAlD
Estradiol—SLCO1C1—renal system—urinary bladder cancer	0.000357	0.00939	CbGeAlD
Estradiol—SLCO4A1—seminal vesicle—urinary bladder cancer	0.000355	0.00934	CbGeAlD
Estradiol—ABCC10—prostate gland—urinary bladder cancer	0.000349	0.00917	CbGeAlD
Estradiol—SLC22A11—renal system—urinary bladder cancer	0.000347	0.00912	CbGeAlD
Estradiol—ESRRA—female reproductive system—urinary bladder cancer	0.000339	0.0089	CbGeAlD
Estradiol—SLCO2B1—prostate gland—urinary bladder cancer	0.000327	0.00859	CbGeAlD
Estradiol—SLCO1B3—vagina—urinary bladder cancer	0.000315	0.00829	CbGeAlD
Estradiol—ESRRA—vagina—urinary bladder cancer	0.000306	0.00805	CbGeAlD
Estradiol—AOX1—seminal vesicle—urinary bladder cancer	0.000303	0.00797	CbGeAlD
Estradiol—UGT1A1—renal system—urinary bladder cancer	0.000303	0.00796	CbGeAlD
Estradiol—SLC22A2—renal system—urinary bladder cancer	0.000301	0.00792	CbGeAlD
Estradiol—SLC22A3—prostate gland—urinary bladder cancer	0.000298	0.00785	CbGeAlD
Estradiol—ABCC10—seminal vesicle—urinary bladder cancer	0.000295	0.00776	CbGeAlD
Estradiol—SLC22A8—prostate gland—urinary bladder cancer	0.000287	0.00755	CbGeAlD
Estradiol—SLCO4A1—renal system—urinary bladder cancer	0.000286	0.00752	CbGeAlD
Estradiol—SLCO4A1—urethra—urinary bladder cancer	0.000281	0.00739	CbGeAlD
Estradiol—Fulvestrant—ESR1—urinary bladder cancer	0.00028	0.0993	CrCbGaD
Estradiol—SLC22A11—female reproductive system—urinary bladder cancer	0.000278	0.0073	CbGeAlD
Estradiol—CYP1B1—prostate gland—urinary bladder cancer	0.000274	0.00721	CbGeAlD
Estradiol—ESR2—epithelium—urinary bladder cancer	0.000274	0.00719	CbGeAlD
Estradiol—ESR2—smooth muscle tissue—urinary bladder cancer	0.000264	0.00693	CbGeAlD
Estradiol—AR—prostate gland—urinary bladder cancer	0.00026	0.00683	CbGeAlD
Estradiol—ESR1—prostate gland—urinary bladder cancer	0.000255	0.0067	CbGeAlD
Estradiol—ESR2—renal system—urinary bladder cancer	0.000254	0.00667	CbGeAlD
Estradiol—SLC22A3—seminal vesicle—urinary bladder cancer	0.000252	0.00664	CbGeAlD
Estradiol—SLCO1B1—renal system—urinary bladder cancer	0.000252	0.00662	CbGeAlD
Estradiol—AOX1—renal system—urinary bladder cancer	0.000244	0.00642	CbGeAlD
Estradiol—AOX1—urethra—urinary bladder cancer	0.00024	0.00631	CbGeAlD
Estradiol—ABCC10—renal system—urinary bladder cancer	0.000238	0.00625	CbGeAlD
Estradiol—ABCC10—urethra—urinary bladder cancer	0.000234	0.00614	CbGeAlD
Estradiol—Trilostane—ESR2—urinary bladder cancer	0.000233	0.0825	CrCbGaD
Estradiol—SLCO4A1—female reproductive system—urinary bladder cancer	0.000229	0.00603	CbGeAlD
Estradiol—SLCO2B1—renal system—urinary bladder cancer	0.000223	0.00585	CbGeAlD
Estradiol—AR—seminal vesicle—urinary bladder cancer	0.00022	0.00578	CbGeAlD
Estradiol—SLC22A1—renal system—urinary bladder cancer	0.000213	0.0056	CbGeAlD
Estradiol—SLC22A3—smooth muscle tissue—urinary bladder cancer	0.000211	0.00556	CbGeAlD
Estradiol—SLCO4A1—vagina—urinary bladder cancer	0.000207	0.00545	CbGeAlD
Estradiol—SLCO1A2—renal system—urinary bladder cancer	0.000205	0.00539	CbGeAlD
Estradiol—ABCG2—prostate gland—urinary bladder cancer	0.000204	0.00537	CbGeAlD
Estradiol—SLC22A3—renal system—urinary bladder cancer	0.000203	0.00535	CbGeAlD
Estradiol—ESR2—female reproductive system—urinary bladder cancer	0.000203	0.00534	CbGeAlD
Estradiol—Estriol—ESR2—urinary bladder cancer	0.000203	0.072	CrCbGaD
Estradiol—SLCO1B1—female reproductive system—urinary bladder cancer	0.000202	0.0053	CbGeAlD
Estradiol—SLC22A3—urethra—urinary bladder cancer	0.0002	0.00525	CbGeAlD
Estradiol—ESRRA—lymph node—urinary bladder cancer	0.000198	0.00521	CbGeAlD
Estradiol—SHBG—female reproductive system—urinary bladder cancer	0.000198	0.00519	CbGeAlD
Estradiol—SLC22A8—renal system—urinary bladder cancer	0.000196	0.00514	CbGeAlD
Estradiol—AOX1—female reproductive system—urinary bladder cancer	0.000196	0.00514	CbGeAlD
Estradiol—CYP1B1—smooth muscle tissue—urinary bladder cancer	0.000194	0.00511	CbGeAlD
Estradiol—AR—epithelium—urinary bladder cancer	0.000191	0.00502	CbGeAlD
Estradiol—ABCC10—female reproductive system—urinary bladder cancer	0.00019	0.00501	CbGeAlD
Estradiol—CYP3A5—prostate gland—urinary bladder cancer	0.00019	0.00498	CbGeAlD
Estradiol—Quinestrol—ESR1—urinary bladder cancer	0.000189	0.0671	CrCbGaD
Estradiol—Estramustine—ESR2—urinary bladder cancer	0.000189	0.0669	CrCbGaD
Estradiol—ESR1—epithelium—urinary bladder cancer	0.000187	0.00493	CbGeAlD
Estradiol—CYP1B1—renal system—urinary bladder cancer	0.000187	0.00492	CbGeAlD
Estradiol—AR—smooth muscle tissue—urinary bladder cancer	0.000184	0.00484	CbGeAlD
Estradiol—ESR2—vagina—urinary bladder cancer	0.000184	0.00483	CbGeAlD
Estradiol—ESR1—smooth muscle tissue—urinary bladder cancer	0.000181	0.00475	CbGeAlD
Estradiol—SHBG—vagina—urinary bladder cancer	0.000179	0.0047	CbGeAlD
Estradiol—SLCO2B1—female reproductive system—urinary bladder cancer	0.000178	0.00469	CbGeAlD
Estradiol—AR—renal system—urinary bladder cancer	0.000177	0.00465	CbGeAlD
Estradiol—AOX1—vagina—urinary bladder cancer	0.000177	0.00465	CbGeAlD
Estradiol—AR—urethra—urinary bladder cancer	0.000174	0.00457	CbGeAlD
Estradiol—ESR1—renal system—urinary bladder cancer	0.000174	0.00457	CbGeAlD
Estradiol—ABCG2—seminal vesicle—urinary bladder cancer	0.000173	0.00454	CbGeAlD
Estradiol—ABCC10—vagina—urinary bladder cancer	0.000172	0.00453	CbGeAlD
Estradiol—SLCO1C1—lymph node—urinary bladder cancer	0.000167	0.0044	CbGeAlD
Estradiol—SLC22A3—female reproductive system—urinary bladder cancer	0.000163	0.00428	CbGeAlD
Estradiol—Estropipate—ESR2—urinary bladder cancer	0.000155	0.0551	CrCbGaD
Estradiol—SLC22A1—vagina—urinary bladder cancer	0.000154	0.00405	CbGeAlD
Estradiol—CYP1B1—female reproductive system—urinary bladder cancer	0.00015	0.00394	CbGeAlD
Estradiol—SLC22A3—vagina—urinary bladder cancer	0.000147	0.00387	CbGeAlD
Estradiol—Trilostane—ESR1—urinary bladder cancer	0.000143	0.0508	CrCbGaD
Estradiol—Mestranol—ESR1—urinary bladder cancer	0.000143	0.0508	CrCbGaD
Estradiol—CYP2C8—renal system—urinary bladder cancer	0.000143	0.00376	CbGeAlD
Estradiol—CYP1A1—epithelium—urinary bladder cancer	0.000142	0.00375	CbGeAlD
Estradiol—AR—female reproductive system—urinary bladder cancer	0.000142	0.00373	CbGeAlD
Estradiol—ESR1—female reproductive system—urinary bladder cancer	0.000139	0.00366	CbGeAlD
Estradiol—ABCG2—urethra—urinary bladder cancer	0.000137	0.0036	CbGeAlD
Estradiol—SLCO4A1—lymph node—urinary bladder cancer	0.000134	0.00352	CbGeAlD
Estradiol—CYP1A2—renal system—urinary bladder cancer	0.000134	0.00352	CbGeAlD
Estradiol—CYP1A1—renal system—urinary bladder cancer	0.000132	0.00347	CbGeAlD
Estradiol—CYP1A1—urethra—urinary bladder cancer	0.00013	0.00341	CbGeAlD
Estradiol—CYP3A5—renal system—urinary bladder cancer	0.000129	0.0034	CbGeAlD
Estradiol—AR—vagina—urinary bladder cancer	0.000128	0.00337	CbGeAlD
Estradiol—ESR1—vagina—urinary bladder cancer	0.000126	0.00331	CbGeAlD
Estradiol—Estriol—ESR1—urinary bladder cancer	0.000125	0.0444	CrCbGaD
Estradiol—ESR2—lymph node—urinary bladder cancer	0.000119	0.00313	CbGeAlD
Estradiol—CYP2C19—vagina—urinary bladder cancer	0.000119	0.00312	CbGeAlD
Estradiol—Estramustine—ESR1—urinary bladder cancer	0.000116	0.0412	CrCbGaD
Estradiol—CYP2C8—female reproductive system—urinary bladder cancer	0.000115	0.00301	CbGeAlD
Estradiol—AOX1—lymph node—urinary bladder cancer	0.000114	0.00301	CbGeAlD
Estradiol—ABCC10—lymph node—urinary bladder cancer	0.000111	0.00293	CbGeAlD
Estradiol—Ethinyl Estradiol—ESR2—urinary bladder cancer	0.000111	0.0393	CrCbGaD
Estradiol—CYP1A1—female reproductive system—urinary bladder cancer	0.000106	0.00278	CbGeAlD
Estradiol—SLCO2B1—lymph node—urinary bladder cancer	0.000104	0.00274	CbGeAlD
Estradiol—CYP2C8—vagina—urinary bladder cancer	0.000104	0.00273	CbGeAlD
Estradiol—CYP2C9—female reproductive system—urinary bladder cancer	0.000102	0.00268	CbGeAlD
Estradiol—ABCG2—vagina—urinary bladder cancer	0.000101	0.00265	CbGeAlD
Estradiol—ABCB1—prostate gland—urinary bladder cancer	0.000101	0.00265	CbGeAlD
Estradiol—CYP3A4—renal system—urinary bladder cancer	9.7e-05	0.00255	CbGeAlD
Estradiol—Conjugated Estrogens—ESR2—urinary bladder cancer	9.69e-05	0.0344	CrCbGaD
Estradiol—Estrone—ESR2—urinary bladder cancer	9.67e-05	0.0343	CrCbGaD
Estradiol—CYP1A1—vagina—urinary bladder cancer	9.57e-05	0.00252	CbGeAlD
Estradiol—Estropipate—ESR1—urinary bladder cancer	9.57e-05	0.0339	CrCbGaD
Estradiol—ALB—lymph node—urinary bladder cancer	9.55e-05	0.00251	CbGeAlD
Estradiol—SLC22A3—lymph node—urinary bladder cancer	9.53e-05	0.00251	CbGeAlD
Estradiol—CYP3A5—vagina—urinary bladder cancer	9.36e-05	0.00246	CbGeAlD
Estradiol—CYP1B1—lymph node—urinary bladder cancer	8.76e-05	0.0023	CbGeAlD
Estradiol—ABCB1—seminal vesicle—urinary bladder cancer	8.52e-05	0.00224	CbGeAlD
Estradiol—AR—lymph node—urinary bladder cancer	8.3e-05	0.00218	CbGeAlD
Estradiol—ESR1—lymph node—urinary bladder cancer	8.14e-05	0.00214	CbGeAlD
Estradiol—CYP3A4—female reproductive system—urinary bladder cancer	7.77e-05	0.00204	CbGeAlD
Estradiol—ABCB1—epithelium—urinary bladder cancer	7.4e-05	0.00195	CbGeAlD
Estradiol—ABCB1—renal system—urinary bladder cancer	6.87e-05	0.0018	CbGeAlD
Estradiol—Ethinyl Estradiol—ESR1—urinary bladder cancer	6.84e-05	0.0242	CrCbGaD
Estradiol—ABCB1—urethra—urinary bladder cancer	6.74e-05	0.00177	CbGeAlD
Estradiol—ABCG2—lymph node—urinary bladder cancer	6.52e-05	0.00171	CbGeAlD
Estradiol—CYP1A1—lymph node—urinary bladder cancer	6.19e-05	0.00163	CbGeAlD
Estradiol—Conjugated Estrogens—ESR1—urinary bladder cancer	5.97e-05	0.0212	CrCbGaD
Estradiol—Estrone—ESR1—urinary bladder cancer	5.95e-05	0.0211	CrCbGaD
Estradiol—ABCB1—female reproductive system—urinary bladder cancer	5.5e-05	0.00145	CbGeAlD
Estradiol—ABCB1—vagina—urinary bladder cancer	4.97e-05	0.00131	CbGeAlD
Estradiol—ABCB1—lymph node—urinary bladder cancer	3.22e-05	0.000846	CbGeAlD
Estradiol—Rhinitis—Epirubicin—urinary bladder cancer	2.61e-05	0.000402	CcSEcCtD
Estradiol—Abdominal pain—Etoposide—urinary bladder cancer	2.61e-05	0.000402	CcSEcCtD
Estradiol—Body temperature increased—Etoposide—urinary bladder cancer	2.61e-05	0.000402	CcSEcCtD
Estradiol—Conjunctivitis—Doxorubicin—urinary bladder cancer	2.61e-05	0.000402	CcSEcCtD
Estradiol—Urinary tract infection—Doxorubicin—urinary bladder cancer	2.61e-05	0.000402	CcSEcCtD
Estradiol—Haemorrhage—Epirubicin—urinary bladder cancer	2.61e-05	0.000401	CcSEcCtD
Estradiol—Hepatitis—Epirubicin—urinary bladder cancer	2.61e-05	0.000401	CcSEcCtD
Estradiol—Eye disorder—Methotrexate—urinary bladder cancer	2.6e-05	0.000401	CcSEcCtD
Estradiol—Diarrhoea—Fluorouracil—urinary bladder cancer	2.6e-05	0.0004	CcSEcCtD
Estradiol—Tinnitus—Methotrexate—urinary bladder cancer	2.6e-05	0.0004	CcSEcCtD
Estradiol—Hypoaesthesia—Epirubicin—urinary bladder cancer	2.59e-05	0.000399	CcSEcCtD
Estradiol—Asthenia—Cisplatin—urinary bladder cancer	2.59e-05	0.000398	CcSEcCtD
Estradiol—Pharyngitis—Epirubicin—urinary bladder cancer	2.59e-05	0.000398	CcSEcCtD
Estradiol—Cardiac disorder—Methotrexate—urinary bladder cancer	2.58e-05	0.000398	CcSEcCtD
Estradiol—Urinary tract disorder—Epirubicin—urinary bladder cancer	2.57e-05	0.000396	CcSEcCtD
Estradiol—Oedema peripheral—Epirubicin—urinary bladder cancer	2.57e-05	0.000395	CcSEcCtD
Estradiol—Haematuria—Doxorubicin—urinary bladder cancer	2.56e-05	0.000394	CcSEcCtD
Estradiol—Connective tissue disorder—Epirubicin—urinary bladder cancer	2.56e-05	0.000394	CcSEcCtD
Estradiol—Urethral disorder—Epirubicin—urinary bladder cancer	2.55e-05	0.000393	CcSEcCtD
Estradiol—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	2.54e-05	0.000391	CcSEcCtD
Estradiol—Epistaxis—Doxorubicin—urinary bladder cancer	2.53e-05	0.00039	CcSEcCtD
Estradiol—Angiopathy—Methotrexate—urinary bladder cancer	2.53e-05	0.000389	CcSEcCtD
Estradiol—Sinusitis—Doxorubicin—urinary bladder cancer	2.52e-05	0.000388	CcSEcCtD
Estradiol—Immune system disorder—Methotrexate—urinary bladder cancer	2.51e-05	0.000387	CcSEcCtD
Estradiol—Dizziness—Fluorouracil—urinary bladder cancer	2.51e-05	0.000387	CcSEcCtD
Estradiol—Visual impairment—Epirubicin—urinary bladder cancer	2.51e-05	0.000387	CcSEcCtD
Estradiol—Mediastinal disorder—Methotrexate—urinary bladder cancer	2.51e-05	0.000386	CcSEcCtD
Estradiol—Chills—Methotrexate—urinary bladder cancer	2.5e-05	0.000385	CcSEcCtD
Estradiol—Diarrhoea—Cisplatin—urinary bladder cancer	2.47e-05	0.00038	CcSEcCtD
Estradiol—Erythema multiforme—Epirubicin—urinary bladder cancer	2.46e-05	0.000379	CcSEcCtD
Estradiol—Alopecia—Methotrexate—urinary bladder cancer	2.46e-05	0.000379	CcSEcCtD
Estradiol—Vomiting—Gemcitabine—urinary bladder cancer	2.46e-05	0.000378	CcSEcCtD
Estradiol—Mental disorder—Methotrexate—urinary bladder cancer	2.44e-05	0.000375	CcSEcCtD
Estradiol—Rash—Gemcitabine—urinary bladder cancer	2.44e-05	0.000375	CcSEcCtD
Estradiol—Dermatitis—Gemcitabine—urinary bladder cancer	2.44e-05	0.000375	CcSEcCtD
Estradiol—Eye disorder—Epirubicin—urinary bladder cancer	2.43e-05	0.000375	CcSEcCtD
Estradiol—Hypersensitivity—Etoposide—urinary bladder cancer	2.43e-05	0.000375	CcSEcCtD
Estradiol—Tinnitus—Epirubicin—urinary bladder cancer	2.43e-05	0.000374	CcSEcCtD
Estradiol—Erythema—Methotrexate—urinary bladder cancer	2.42e-05	0.000373	CcSEcCtD
Estradiol—Malnutrition—Methotrexate—urinary bladder cancer	2.42e-05	0.000373	CcSEcCtD
Estradiol—Haemoglobin—Doxorubicin—urinary bladder cancer	2.42e-05	0.000373	CcSEcCtD
Estradiol—Headache—Gemcitabine—urinary bladder cancer	2.42e-05	0.000373	CcSEcCtD
Estradiol—Flushing—Epirubicin—urinary bladder cancer	2.42e-05	0.000372	CcSEcCtD
Estradiol—Cardiac disorder—Epirubicin—urinary bladder cancer	2.42e-05	0.000372	CcSEcCtD
Estradiol—Vomiting—Fluorouracil—urinary bladder cancer	2.42e-05	0.000372	CcSEcCtD
Estradiol—Rhinitis—Doxorubicin—urinary bladder cancer	2.42e-05	0.000372	CcSEcCtD
Estradiol—Haemorrhage—Doxorubicin—urinary bladder cancer	2.41e-05	0.000371	CcSEcCtD
Estradiol—Hepatitis—Doxorubicin—urinary bladder cancer	2.41e-05	0.000371	CcSEcCtD
Estradiol—Hypoaesthesia—Doxorubicin—urinary bladder cancer	2.4e-05	0.000369	CcSEcCtD
Estradiol—Rash—Fluorouracil—urinary bladder cancer	2.4e-05	0.000369	CcSEcCtD
Estradiol—Dermatitis—Fluorouracil—urinary bladder cancer	2.4e-05	0.000369	CcSEcCtD
Estradiol—Pharyngitis—Doxorubicin—urinary bladder cancer	2.39e-05	0.000368	CcSEcCtD
Estradiol—Headache—Fluorouracil—urinary bladder cancer	2.38e-05	0.000367	CcSEcCtD
Estradiol—Urinary tract disorder—Doxorubicin—urinary bladder cancer	2.38e-05	0.000366	CcSEcCtD
Estradiol—Oedema peripheral—Doxorubicin—urinary bladder cancer	2.37e-05	0.000366	CcSEcCtD
Estradiol—Dysgeusia—Methotrexate—urinary bladder cancer	2.37e-05	0.000365	CcSEcCtD
Estradiol—Asthenia—Etoposide—urinary bladder cancer	2.37e-05	0.000365	CcSEcCtD
Estradiol—Connective tissue disorder—Doxorubicin—urinary bladder cancer	2.37e-05	0.000365	CcSEcCtD
Estradiol—Angiopathy—Epirubicin—urinary bladder cancer	2.36e-05	0.000364	CcSEcCtD
Estradiol—Urethral disorder—Doxorubicin—urinary bladder cancer	2.36e-05	0.000364	CcSEcCtD
Estradiol—Immune system disorder—Epirubicin—urinary bladder cancer	2.35e-05	0.000362	CcSEcCtD
Estradiol—Mediastinal disorder—Epirubicin—urinary bladder cancer	2.35e-05	0.000361	CcSEcCtD
Estradiol—Back pain—Methotrexate—urinary bladder cancer	2.34e-05	0.000361	CcSEcCtD
Estradiol—Chills—Epirubicin—urinary bladder cancer	2.34e-05	0.00036	CcSEcCtD
Estradiol—Pruritus—Etoposide—urinary bladder cancer	2.34e-05	0.00036	CcSEcCtD
Estradiol—Visual impairment—Doxorubicin—urinary bladder cancer	2.32e-05	0.000358	CcSEcCtD
Estradiol—Alopecia—Epirubicin—urinary bladder cancer	2.3e-05	0.000354	CcSEcCtD
Estradiol—Nausea—Gemcitabine—urinary bladder cancer	2.3e-05	0.000354	CcSEcCtD
Estradiol—Vomiting—Cisplatin—urinary bladder cancer	2.29e-05	0.000353	CcSEcCtD
Estradiol—Mental disorder—Epirubicin—urinary bladder cancer	2.28e-05	0.000351	CcSEcCtD
Estradiol—Erythema multiforme—Doxorubicin—urinary bladder cancer	2.28e-05	0.000351	CcSEcCtD
Estradiol—Rash—Cisplatin—urinary bladder cancer	2.27e-05	0.00035	CcSEcCtD
Estradiol—Dermatitis—Cisplatin—urinary bladder cancer	2.27e-05	0.00035	CcSEcCtD
Estradiol—Erythema—Epirubicin—urinary bladder cancer	2.27e-05	0.000349	CcSEcCtD
Estradiol—Malnutrition—Epirubicin—urinary bladder cancer	2.27e-05	0.000349	CcSEcCtD
Estradiol—Diarrhoea—Etoposide—urinary bladder cancer	2.26e-05	0.000348	CcSEcCtD
Estradiol—Nausea—Fluorouracil—urinary bladder cancer	2.26e-05	0.000348	CcSEcCtD
Estradiol—Eye disorder—Doxorubicin—urinary bladder cancer	2.25e-05	0.000347	CcSEcCtD
Estradiol—Ill-defined disorder—Methotrexate—urinary bladder cancer	2.25e-05	0.000346	CcSEcCtD
Estradiol—Tinnitus—Doxorubicin—urinary bladder cancer	2.25e-05	0.000346	CcSEcCtD
Estradiol—Flushing—Doxorubicin—urinary bladder cancer	2.24e-05	0.000344	CcSEcCtD
Estradiol—Cardiac disorder—Doxorubicin—urinary bladder cancer	2.24e-05	0.000344	CcSEcCtD
Estradiol—Flatulence—Epirubicin—urinary bladder cancer	2.23e-05	0.000344	CcSEcCtD
Estradiol—Tension—Epirubicin—urinary bladder cancer	2.23e-05	0.000343	CcSEcCtD
Estradiol—Dysgeusia—Epirubicin—urinary bladder cancer	2.22e-05	0.000342	CcSEcCtD
Estradiol—Nervousness—Epirubicin—urinary bladder cancer	2.2e-05	0.000339	CcSEcCtD
Estradiol—Back pain—Epirubicin—urinary bladder cancer	2.19e-05	0.000338	CcSEcCtD
Estradiol—Angiopathy—Doxorubicin—urinary bladder cancer	2.19e-05	0.000337	CcSEcCtD
Estradiol—Malaise—Methotrexate—urinary bladder cancer	2.19e-05	0.000336	CcSEcCtD
Estradiol—Dizziness—Etoposide—urinary bladder cancer	2.18e-05	0.000336	CcSEcCtD
Estradiol—Muscle spasms—Epirubicin—urinary bladder cancer	2.18e-05	0.000336	CcSEcCtD
Estradiol—Immune system disorder—Doxorubicin—urinary bladder cancer	2.18e-05	0.000335	CcSEcCtD
Estradiol—Vertigo—Methotrexate—urinary bladder cancer	2.18e-05	0.000335	CcSEcCtD
Estradiol—Mediastinal disorder—Doxorubicin—urinary bladder cancer	2.17e-05	0.000334	CcSEcCtD
Estradiol—Chills—Doxorubicin—urinary bladder cancer	2.16e-05	0.000333	CcSEcCtD
Estradiol—Nausea—Cisplatin—urinary bladder cancer	2.14e-05	0.00033	CcSEcCtD
Estradiol—Alopecia—Doxorubicin—urinary bladder cancer	2.13e-05	0.000328	CcSEcCtD
Estradiol—Cough—Methotrexate—urinary bladder cancer	2.11e-05	0.000326	CcSEcCtD
Estradiol—Mental disorder—Doxorubicin—urinary bladder cancer	2.11e-05	0.000325	CcSEcCtD
Estradiol—Ill-defined disorder—Epirubicin—urinary bladder cancer	2.1e-05	0.000324	CcSEcCtD
Estradiol—Vomiting—Etoposide—urinary bladder cancer	2.1e-05	0.000323	CcSEcCtD
Estradiol—Erythema—Doxorubicin—urinary bladder cancer	2.1e-05	0.000323	CcSEcCtD
Estradiol—Malnutrition—Doxorubicin—urinary bladder cancer	2.1e-05	0.000323	CcSEcCtD
Estradiol—Agitation—Epirubicin—urinary bladder cancer	2.08e-05	0.000321	CcSEcCtD
Estradiol—Rash—Etoposide—urinary bladder cancer	2.08e-05	0.000321	CcSEcCtD
Estradiol—Dermatitis—Etoposide—urinary bladder cancer	2.08e-05	0.00032	CcSEcCtD
Estradiol—Headache—Etoposide—urinary bladder cancer	2.07e-05	0.000318	CcSEcCtD
Estradiol—Flatulence—Doxorubicin—urinary bladder cancer	2.07e-05	0.000318	CcSEcCtD
Estradiol—Arthralgia—Methotrexate—urinary bladder cancer	2.06e-05	0.000318	CcSEcCtD
Estradiol—Chest pain—Methotrexate—urinary bladder cancer	2.06e-05	0.000318	CcSEcCtD
Estradiol—Myalgia—Methotrexate—urinary bladder cancer	2.06e-05	0.000318	CcSEcCtD
Estradiol—Tension—Doxorubicin—urinary bladder cancer	2.06e-05	0.000317	CcSEcCtD
Estradiol—Dysgeusia—Doxorubicin—urinary bladder cancer	2.06e-05	0.000316	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	2.05e-05	0.000315	CcSEcCtD
Estradiol—Malaise—Epirubicin—urinary bladder cancer	2.05e-05	0.000315	CcSEcCtD
Estradiol—Discomfort—Methotrexate—urinary bladder cancer	2.04e-05	0.000314	CcSEcCtD
Estradiol—Nervousness—Doxorubicin—urinary bladder cancer	2.04e-05	0.000314	CcSEcCtD
Estradiol—Vertigo—Epirubicin—urinary bladder cancer	2.04e-05	0.000314	CcSEcCtD
Estradiol—Syncope—Epirubicin—urinary bladder cancer	2.03e-05	0.000313	CcSEcCtD
Estradiol—Back pain—Doxorubicin—urinary bladder cancer	2.03e-05	0.000312	CcSEcCtD
Estradiol—Muscle spasms—Doxorubicin—urinary bladder cancer	2.02e-05	0.000311	CcSEcCtD
Estradiol—Palpitations—Epirubicin—urinary bladder cancer	2e-05	0.000309	CcSEcCtD
Estradiol—Confusional state—Methotrexate—urinary bladder cancer	1.99e-05	0.000307	CcSEcCtD
Estradiol—Loss of consciousness—Epirubicin—urinary bladder cancer	1.99e-05	0.000307	CcSEcCtD
Estradiol—Cough—Epirubicin—urinary bladder cancer	1.98e-05	0.000305	CcSEcCtD
Estradiol—Anaphylactic shock—Methotrexate—urinary bladder cancer	1.98e-05	0.000304	CcSEcCtD
Estradiol—Infection—Methotrexate—urinary bladder cancer	1.96e-05	0.000302	CcSEcCtD
Estradiol—Nausea—Etoposide—urinary bladder cancer	1.96e-05	0.000302	CcSEcCtD
Estradiol—Hypertension—Epirubicin—urinary bladder cancer	1.96e-05	0.000301	CcSEcCtD
Estradiol—Ill-defined disorder—Doxorubicin—urinary bladder cancer	1.95e-05	0.0003	CcSEcCtD
Estradiol—Nervous system disorder—Methotrexate—urinary bladder cancer	1.94e-05	0.000299	CcSEcCtD
Estradiol—Chest pain—Epirubicin—urinary bladder cancer	1.93e-05	0.000297	CcSEcCtD
Estradiol—Arthralgia—Epirubicin—urinary bladder cancer	1.93e-05	0.000297	CcSEcCtD
Estradiol—Myalgia—Epirubicin—urinary bladder cancer	1.93e-05	0.000297	CcSEcCtD
Estradiol—Agitation—Doxorubicin—urinary bladder cancer	1.93e-05	0.000297	CcSEcCtD
Estradiol—Anxiety—Epirubicin—urinary bladder cancer	1.92e-05	0.000296	CcSEcCtD
Estradiol—Skin disorder—Methotrexate—urinary bladder cancer	1.92e-05	0.000296	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	1.92e-05	0.000295	CcSEcCtD
Estradiol—Hyperhidrosis—Methotrexate—urinary bladder cancer	1.91e-05	0.000294	CcSEcCtD
Estradiol—Discomfort—Epirubicin—urinary bladder cancer	1.91e-05	0.000294	CcSEcCtD
Estradiol—Malaise—Doxorubicin—urinary bladder cancer	1.89e-05	0.000291	CcSEcCtD
Estradiol—Dry mouth—Epirubicin—urinary bladder cancer	1.89e-05	0.000291	CcSEcCtD
Estradiol—Vertigo—Doxorubicin—urinary bladder cancer	1.89e-05	0.00029	CcSEcCtD
Estradiol—Syncope—Doxorubicin—urinary bladder cancer	1.88e-05	0.00029	CcSEcCtD
Estradiol—Confusional state—Epirubicin—urinary bladder cancer	1.87e-05	0.000287	CcSEcCtD
Estradiol—Palpitations—Doxorubicin—urinary bladder cancer	1.85e-05	0.000285	CcSEcCtD
Estradiol—Anaphylactic shock—Epirubicin—urinary bladder cancer	1.85e-05	0.000285	CcSEcCtD
Estradiol—Oedema—Epirubicin—urinary bladder cancer	1.85e-05	0.000285	CcSEcCtD
Estradiol—Loss of consciousness—Doxorubicin—urinary bladder cancer	1.84e-05	0.000284	CcSEcCtD
Estradiol—Infection—Epirubicin—urinary bladder cancer	1.84e-05	0.000283	CcSEcCtD
Estradiol—Cough—Doxorubicin—urinary bladder cancer	1.83e-05	0.000282	CcSEcCtD
Estradiol—Shock—Epirubicin—urinary bladder cancer	1.82e-05	0.00028	CcSEcCtD
Estradiol—Nervous system disorder—Epirubicin—urinary bladder cancer	1.82e-05	0.000279	CcSEcCtD
Estradiol—Hypertension—Doxorubicin—urinary bladder cancer	1.81e-05	0.000279	CcSEcCtD
Estradiol—Tachycardia—Epirubicin—urinary bladder cancer	1.81e-05	0.000278	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	1.8e-05	0.000277	CcSEcCtD
Estradiol—Skin disorder—Epirubicin—urinary bladder cancer	1.8e-05	0.000277	CcSEcCtD
Estradiol—Hyperhidrosis—Epirubicin—urinary bladder cancer	1.79e-05	0.000275	CcSEcCtD
Estradiol—Insomnia—Methotrexate—urinary bladder cancer	1.79e-05	0.000275	CcSEcCtD
Estradiol—Myalgia—Doxorubicin—urinary bladder cancer	1.79e-05	0.000275	CcSEcCtD
Estradiol—Arthralgia—Doxorubicin—urinary bladder cancer	1.79e-05	0.000275	CcSEcCtD
Estradiol—Chest pain—Doxorubicin—urinary bladder cancer	1.79e-05	0.000275	CcSEcCtD
Estradiol—Anxiety—Doxorubicin—urinary bladder cancer	1.78e-05	0.000274	CcSEcCtD
Estradiol—Paraesthesia—Methotrexate—urinary bladder cancer	1.78e-05	0.000273	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	1.77e-05	0.000273	CcSEcCtD
Estradiol—Discomfort—Doxorubicin—urinary bladder cancer	1.77e-05	0.000272	CcSEcCtD
Estradiol—Dyspnoea—Methotrexate—urinary bladder cancer	1.76e-05	0.000271	CcSEcCtD
Estradiol—Somnolence—Methotrexate—urinary bladder cancer	1.76e-05	0.000271	CcSEcCtD
Estradiol—Dry mouth—Doxorubicin—urinary bladder cancer	1.75e-05	0.000269	CcSEcCtD
Estradiol—Dyspepsia—Methotrexate—urinary bladder cancer	1.74e-05	0.000268	CcSEcCtD
Estradiol—Confusional state—Doxorubicin—urinary bladder cancer	1.73e-05	0.000266	CcSEcCtD
Estradiol—Decreased appetite—Methotrexate—urinary bladder cancer	1.72e-05	0.000265	CcSEcCtD
Estradiol—Oedema—Doxorubicin—urinary bladder cancer	1.71e-05	0.000264	CcSEcCtD
Estradiol—Anaphylactic shock—Doxorubicin—urinary bladder cancer	1.71e-05	0.000264	CcSEcCtD
Estradiol—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	1.71e-05	0.000263	CcSEcCtD
Estradiol—Fatigue—Methotrexate—urinary bladder cancer	1.71e-05	0.000263	CcSEcCtD
Estradiol—Infection—Doxorubicin—urinary bladder cancer	1.7e-05	0.000262	CcSEcCtD
Estradiol—Pain—Methotrexate—urinary bladder cancer	1.69e-05	0.00026	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	1.69e-05	0.00026	CcSEcCtD
Estradiol—Shock—Doxorubicin—urinary bladder cancer	1.69e-05	0.000259	CcSEcCtD
Estradiol—Nervous system disorder—Doxorubicin—urinary bladder cancer	1.68e-05	0.000259	CcSEcCtD
Estradiol—Insomnia—Epirubicin—urinary bladder cancer	1.67e-05	0.000258	CcSEcCtD
Estradiol—Tachycardia—Doxorubicin—urinary bladder cancer	1.67e-05	0.000257	CcSEcCtD
Estradiol—Skin disorder—Doxorubicin—urinary bladder cancer	1.66e-05	0.000256	CcSEcCtD
Estradiol—Paraesthesia—Epirubicin—urinary bladder cancer	1.66e-05	0.000256	CcSEcCtD
Estradiol—Hyperhidrosis—Doxorubicin—urinary bladder cancer	1.66e-05	0.000255	CcSEcCtD
Estradiol—Dyspnoea—Epirubicin—urinary bladder cancer	1.65e-05	0.000254	CcSEcCtD
Estradiol—Somnolence—Epirubicin—urinary bladder cancer	1.65e-05	0.000253	CcSEcCtD
Estradiol—Feeling abnormal—Methotrexate—urinary bladder cancer	1.63e-05	0.000251	CcSEcCtD
Estradiol—Dyspepsia—Epirubicin—urinary bladder cancer	1.63e-05	0.000251	CcSEcCtD
Estradiol—Gastrointestinal pain—Methotrexate—urinary bladder cancer	1.62e-05	0.000249	CcSEcCtD
Estradiol—Decreased appetite—Epirubicin—urinary bladder cancer	1.61e-05	0.000248	CcSEcCtD
Estradiol—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	1.6e-05	0.000246	CcSEcCtD
Estradiol—Fatigue—Epirubicin—urinary bladder cancer	1.6e-05	0.000246	CcSEcCtD
Estradiol—Constipation—Epirubicin—urinary bladder cancer	1.58e-05	0.000244	CcSEcCtD
Estradiol—Pain—Epirubicin—urinary bladder cancer	1.58e-05	0.000244	CcSEcCtD
Estradiol—Urticaria—Methotrexate—urinary bladder cancer	1.57e-05	0.000242	CcSEcCtD
Estradiol—Body temperature increased—Methotrexate—urinary bladder cancer	1.56e-05	0.000241	CcSEcCtD
Estradiol—Abdominal pain—Methotrexate—urinary bladder cancer	1.56e-05	0.000241	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	1.56e-05	0.00024	CcSEcCtD
Estradiol—Insomnia—Doxorubicin—urinary bladder cancer	1.55e-05	0.000238	CcSEcCtD
Estradiol—Paraesthesia—Doxorubicin—urinary bladder cancer	1.54e-05	0.000237	CcSEcCtD
Estradiol—Dyspnoea—Doxorubicin—urinary bladder cancer	1.53e-05	0.000235	CcSEcCtD
Estradiol—Feeling abnormal—Epirubicin—urinary bladder cancer	1.53e-05	0.000235	CcSEcCtD
Estradiol—Somnolence—Doxorubicin—urinary bladder cancer	1.52e-05	0.000234	CcSEcCtD
Estradiol—Gastrointestinal pain—Epirubicin—urinary bladder cancer	1.51e-05	0.000233	CcSEcCtD
Estradiol—Dyspepsia—Doxorubicin—urinary bladder cancer	1.51e-05	0.000232	CcSEcCtD
Estradiol—Decreased appetite—Doxorubicin—urinary bladder cancer	1.49e-05	0.000229	CcSEcCtD
Estradiol—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	1.48e-05	0.000228	CcSEcCtD
Estradiol—Fatigue—Doxorubicin—urinary bladder cancer	1.48e-05	0.000227	CcSEcCtD
Estradiol—Urticaria—Epirubicin—urinary bladder cancer	1.47e-05	0.000226	CcSEcCtD
Estradiol—Constipation—Doxorubicin—urinary bladder cancer	1.46e-05	0.000225	CcSEcCtD
Estradiol—Pain—Doxorubicin—urinary bladder cancer	1.46e-05	0.000225	CcSEcCtD
Estradiol—Abdominal pain—Epirubicin—urinary bladder cancer	1.46e-05	0.000225	CcSEcCtD
Estradiol—Body temperature increased—Epirubicin—urinary bladder cancer	1.46e-05	0.000225	CcSEcCtD
Estradiol—Hypersensitivity—Methotrexate—urinary bladder cancer	1.46e-05	0.000224	CcSEcCtD
Estradiol—Asthenia—Methotrexate—urinary bladder cancer	1.42e-05	0.000218	CcSEcCtD
Estradiol—Feeling abnormal—Doxorubicin—urinary bladder cancer	1.41e-05	0.000217	CcSEcCtD
Estradiol—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	1.4e-05	0.000216	CcSEcCtD
Estradiol—Pruritus—Methotrexate—urinary bladder cancer	1.4e-05	0.000215	CcSEcCtD
Estradiol—Hypersensitivity—Epirubicin—urinary bladder cancer	1.36e-05	0.00021	CcSEcCtD
Estradiol—Urticaria—Doxorubicin—urinary bladder cancer	1.36e-05	0.000209	CcSEcCtD
Estradiol—Abdominal pain—Doxorubicin—urinary bladder cancer	1.35e-05	0.000208	CcSEcCtD
Estradiol—Body temperature increased—Doxorubicin—urinary bladder cancer	1.35e-05	0.000208	CcSEcCtD
Estradiol—Diarrhoea—Methotrexate—urinary bladder cancer	1.35e-05	0.000208	CcSEcCtD
Estradiol—Asthenia—Epirubicin—urinary bladder cancer	1.33e-05	0.000204	CcSEcCtD
Estradiol—Pruritus—Epirubicin—urinary bladder cancer	1.31e-05	0.000202	CcSEcCtD
Estradiol—Dizziness—Methotrexate—urinary bladder cancer	1.31e-05	0.000201	CcSEcCtD
Estradiol—Diarrhoea—Epirubicin—urinary bladder cancer	1.27e-05	0.000195	CcSEcCtD
Estradiol—Hypersensitivity—Doxorubicin—urinary bladder cancer	1.26e-05	0.000194	CcSEcCtD
Estradiol—Vomiting—Methotrexate—urinary bladder cancer	1.26e-05	0.000194	CcSEcCtD
Estradiol—Rash—Methotrexate—urinary bladder cancer	1.25e-05	0.000192	CcSEcCtD
Estradiol—Dermatitis—Methotrexate—urinary bladder cancer	1.25e-05	0.000192	CcSEcCtD
Estradiol—Headache—Methotrexate—urinary bladder cancer	1.24e-05	0.000191	CcSEcCtD
Estradiol—Asthenia—Doxorubicin—urinary bladder cancer	1.23e-05	0.000189	CcSEcCtD
Estradiol—Dizziness—Epirubicin—urinary bladder cancer	1.22e-05	0.000188	CcSEcCtD
Estradiol—Pruritus—Doxorubicin—urinary bladder cancer	1.21e-05	0.000187	CcSEcCtD
Estradiol—Vomiting—Epirubicin—urinary bladder cancer	1.18e-05	0.000181	CcSEcCtD
Estradiol—Nausea—Methotrexate—urinary bladder cancer	1.17e-05	0.000181	CcSEcCtD
Estradiol—Diarrhoea—Doxorubicin—urinary bladder cancer	1.17e-05	0.00018	CcSEcCtD
Estradiol—Rash—Epirubicin—urinary bladder cancer	1.17e-05	0.00018	CcSEcCtD
Estradiol—Dermatitis—Epirubicin—urinary bladder cancer	1.17e-05	0.000179	CcSEcCtD
Estradiol—Headache—Epirubicin—urinary bladder cancer	1.16e-05	0.000179	CcSEcCtD
Estradiol—Dizziness—Doxorubicin—urinary bladder cancer	1.13e-05	0.000174	CcSEcCtD
Estradiol—Nausea—Epirubicin—urinary bladder cancer	1.1e-05	0.000169	CcSEcCtD
Estradiol—Vomiting—Doxorubicin—urinary bladder cancer	1.09e-05	0.000168	CcSEcCtD
Estradiol—Rash—Doxorubicin—urinary bladder cancer	1.08e-05	0.000166	CcSEcCtD
Estradiol—Dermatitis—Doxorubicin—urinary bladder cancer	1.08e-05	0.000166	CcSEcCtD
Estradiol—Headache—Doxorubicin—urinary bladder cancer	1.07e-05	0.000165	CcSEcCtD
Estradiol—Nausea—Doxorubicin—urinary bladder cancer	1.02e-05	0.000157	CcSEcCtD
Estradiol—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	2.64e-06	5.57e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—ERCC2—urinary bladder cancer	2.64e-06	5.56e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.63e-06	5.55e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—NCOR1—urinary bladder cancer	2.62e-06	5.51e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—GSTM1—urinary bladder cancer	2.62e-06	5.51e-05	CbGpPWpGaD
Estradiol—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.57e-06	5.42e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PTGS2—urinary bladder cancer	2.57e-06	5.42e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	2.57e-06	5.41e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—CREBBP—urinary bladder cancer	2.56e-06	5.41e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.54e-06	5.36e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.54e-06	5.36e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.53e-06	5.33e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PTGS2—urinary bladder cancer	2.52e-06	5.32e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—MTHFR—urinary bladder cancer	2.51e-06	5.28e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—GPX1—urinary bladder cancer	2.5e-06	5.28e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—NQO1—urinary bladder cancer	2.5e-06	5.28e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.5e-06	5.28e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	2.48e-06	5.24e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.48e-06	5.23e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.48e-06	5.23e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—MTHFR—urinary bladder cancer	2.48e-06	5.23e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.48e-06	5.22e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.47e-06	5.2e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	2.46e-06	5.2e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—ERCC2—urinary bladder cancer	2.46e-06	5.18e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.43e-06	5.12e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.43e-06	5.12e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—NCOR1—urinary bladder cancer	2.42e-06	5.11e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.41e-06	5.07e-05	CbGpPWpGaD
Estradiol—AOX1—Disease—HRAS—urinary bladder cancer	2.4e-06	5.05e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PPARG—urinary bladder cancer	2.39e-06	5.05e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.32e-06	4.89e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.32e-06	4.89e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—MTHFR—urinary bladder cancer	2.31e-06	4.87e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.3e-06	4.86e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—CREBBP—urinary bladder cancer	2.3e-06	4.85e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—NQO1—urinary bladder cancer	2.3e-06	4.84e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—NQO1—urinary bladder cancer	2.28e-06	4.81e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—IL2—urinary bladder cancer	2.25e-06	4.75e-05	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.25e-06	4.75e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.25e-06	4.74e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PTEN—urinary bladder cancer	2.24e-06	4.72e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PPARG—urinary bladder cancer	2.23e-06	4.71e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.23e-06	4.7e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.21e-06	4.67e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.21e-06	4.67e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	2.21e-06	4.66e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PTEN—urinary bladder cancer	2.2e-06	4.64e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	2.19e-06	4.63e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—CREBBP—urinary bladder cancer	2.15e-06	4.52e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.14e-06	4.51e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—EP300—urinary bladder cancer	2.14e-06	4.5e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TERT—urinary bladder cancer	2.13e-06	4.5e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.12e-06	4.47e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.11e-06	4.46e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	2.11e-06	4.44e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—EP300—urinary bladder cancer	2.1e-06	4.42e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	2.09e-06	4.4e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—TYMS—urinary bladder cancer	2.05e-06	4.33e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.05e-06	4.32e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PPARG—urinary bladder cancer	2.03e-06	4.28e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	2.03e-06	4.28e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	2.03e-06	4.28e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—EP300—urinary bladder cancer	2.02e-06	4.26e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.02e-06	4.26e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	2.02e-06	4.26e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PPARG—urinary bladder cancer	2.01e-06	4.25e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PPARG—urinary bladder cancer	2.01e-06	4.24e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—NQO1—urinary bladder cancer	2e-06	4.22e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.99e-06	4.19e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.98e-06	4.18e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.98e-06	4.18e-05	CbGpPWpGaD
Estradiol—AR—Gene Expression—MYC—urinary bladder cancer	1.98e-06	4.17e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.97e-06	4.15e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—SRC—urinary bladder cancer	1.97e-06	4.15e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—FGFR3—urinary bladder cancer	1.96e-06	4.13e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—CREBBP—urinary bladder cancer	1.95e-06	4.11e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.95e-06	4.1e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.94e-06	4.09e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—TYMS—urinary bladder cancer	1.94e-06	4.09e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	1.93e-06	4.08e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—CREBBP—urinary bladder cancer	1.93e-06	4.07e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.93e-06	4.07e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.92e-06	4.05e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	1.92e-06	4.05e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	1.92e-06	4.05e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.91e-06	4.04e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.91e-06	4.03e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.91e-06	4.03e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—GSTP1—urinary bladder cancer	1.9e-06	4.01e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.89e-06	3.99e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PTGS2—urinary bladder cancer	1.88e-06	3.97e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PPARG—urinary bladder cancer	1.87e-06	3.95e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.87e-06	3.94e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.85e-06	3.91e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.84e-06	3.88e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—GPX1—urinary bladder cancer	1.84e-06	3.87e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.81e-06	3.82e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	1.8e-06	3.8e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—CREBBP—urinary bladder cancer	1.8e-06	3.8e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.8e-06	3.78e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.78e-06	3.75e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—TYMS—urinary bladder cancer	1.77e-06	3.73e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	1.76e-06	3.71e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.76e-06	3.71e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.76e-06	3.71e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PTGS2—urinary bladder cancer	1.76e-06	3.7e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—NCOR1—urinary bladder cancer	1.75e-06	3.69e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—GSTM1—urinary bladder cancer	1.75e-06	3.69e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.73e-06	3.65e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	1.73e-06	3.64e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.71e-06	3.6e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	1.7e-06	3.58e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.68e-06	3.55e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—EP300—urinary bladder cancer	1.68e-06	3.54e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—GPX1—urinary bladder cancer	1.68e-06	3.53e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.67e-06	3.52e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CREBBP—urinary bladder cancer	1.67e-06	3.52e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.65e-06	3.49e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.65e-06	3.49e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.65e-06	3.48e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IGF1—urinary bladder cancer	1.65e-06	3.47e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—ERCC2—urinary bladder cancer	1.64e-06	3.47e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PTEN—urinary bladder cancer	1.64e-06	3.46e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—KRAS—urinary bladder cancer	1.63e-06	3.43e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PTGS2—urinary bladder cancer	1.6e-06	3.37e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.6e-06	3.37e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.59e-06	3.35e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	1.58e-06	3.34e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PTGS2—urinary bladder cancer	1.58e-06	3.33e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.58e-06	3.33e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.57e-06	3.31e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.57e-06	3.31e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—EP300—urinary bladder cancer	1.57e-06	3.3e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.56e-06	3.28e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.55e-06	3.28e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.55e-06	3.27e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.55e-06	3.27e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—MTHFR—urinary bladder cancer	1.55e-06	3.26e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.53e-06	3.23e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.53e-06	3.23e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PTEN—urinary bladder cancer	1.53e-06	3.23e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.53e-06	3.22e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.53e-06	3.22e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—MYC—urinary bladder cancer	1.52e-06	3.21e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—RHOA—urinary bladder cancer	1.51e-06	3.18e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.51e-06	3.18e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	1.51e-06	3.17e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.5e-06	3.17e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.48e-06	3.13e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.48e-06	3.11e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PTGS2—urinary bladder cancer	1.47e-06	3.11e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.47e-06	3.09e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—EP300—urinary bladder cancer	1.46e-06	3.08e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.46e-06	3.07e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.45e-06	3.05e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—TP53—urinary bladder cancer	1.45e-06	3.05e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.44e-06	3.04e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—EP300—urinary bladder cancer	1.44e-06	3.03e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.43e-06	3.02e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.43e-06	3.02e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.4e-06	2.95e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—ERBB2—urinary bladder cancer	1.4e-06	2.94e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PTEN—urinary bladder cancer	1.39e-06	2.94e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.39e-06	2.93e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—HRAS—urinary bladder cancer	1.38e-06	2.92e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PTEN—urinary bladder cancer	1.38e-06	2.91e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PTEN—urinary bladder cancer	1.38e-06	2.91e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PPARG—urinary bladder cancer	1.38e-06	2.9e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.37e-06	2.89e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.35e-06	2.86e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.35e-06	2.85e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.35e-06	2.84e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.33e-06	2.81e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—EP300—urinary bladder cancer	1.33e-06	2.8e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CXCL8—urinary bladder cancer	1.32e-06	2.79e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	1.32e-06	2.79e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—EP300—urinary bladder cancer	1.32e-06	2.78e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—EP300—urinary bladder cancer	1.32e-06	2.77e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.29e-06	2.72e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PTEN—urinary bladder cancer	1.29e-06	2.71e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL2—urinary bladder cancer	1.27e-06	2.67e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.27e-06	2.67e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.26e-06	2.66e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PPARG—urinary bladder cancer	1.25e-06	2.64e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.24e-06	2.61e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCND1—urinary bladder cancer	1.23e-06	2.6e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.23e-06	2.6e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—EP300—urinary bladder cancer	1.23e-06	2.58e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.22e-06	2.58e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.22e-06	2.58e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.21e-06	2.55e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—CREBBP—urinary bladder cancer	1.2e-06	2.54e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MMP9—urinary bladder cancer	1.2e-06	2.53e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.19e-06	2.52e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PTEN—urinary bladder cancer	1.19e-06	2.51e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.17e-06	2.47e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.15e-06	2.43e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.15e-06	2.41e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—EP300—urinary bladder cancer	1.14e-06	2.39e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.13e-06	2.37e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—SRC—urinary bladder cancer	1.1e-06	2.33e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.1e-06	2.32e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	1.08e-06	2.28e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.08e-06	2.28e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.08e-06	2.28e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.06e-06	2.22e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.03e-06	2.17e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.03e-06	2.16e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PTEN—urinary bladder cancer	9.99e-07	2.11e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	9.92e-07	2.09e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MYC—urinary bladder cancer	9.9e-07	2.09e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTGS2—urinary bladder cancer	9.86e-07	2.08e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	9.86e-07	2.08e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—EGFR—urinary bladder cancer	9.68e-07	2.04e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—TYMS—urinary bladder cancer	9.55e-07	2.01e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—EP300—urinary bladder cancer	9.52e-07	2.01e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	9.44e-07	1.99e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	9.44e-07	1.99e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PTEN—urinary bladder cancer	9.43e-07	1.99e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—KRAS—urinary bladder cancer	9.14e-07	1.93e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GPX1—urinary bladder cancer	9.04e-07	1.91e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—EP300—urinary bladder cancer	9e-07	1.9e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	8.88e-07	1.87e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	8.85e-07	1.87e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PPARG—urinary bladder cancer	8.77e-07	1.85e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTEN—urinary bladder cancer	8.65e-07	1.82e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTGS2—urinary bladder cancer	8.64e-07	1.82e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTEN—urinary bladder cancer	8.6e-07	1.81e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	8.42e-07	1.78e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	8.35e-07	1.76e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—EP300—urinary bladder cancer	8.25e-07	1.74e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—EP300—urinary bladder cancer	8.2e-07	1.73e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TP53—urinary bladder cancer	8.13e-07	1.71e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	8.07e-07	1.7e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—HRAS—urinary bladder cancer	7.77e-07	1.64e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTEN—urinary bladder cancer	7.72e-07	1.63e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTEN—urinary bladder cancer	7.54e-07	1.59e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—EP300—urinary bladder cancer	7.36e-07	1.55e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—EP300—urinary bladder cancer	7.19e-07	1.52e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTEN—urinary bladder cancer	7.04e-07	1.48e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	6.9e-07	1.45e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.77e-07	1.43e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—EP300—urinary bladder cancer	6.71e-07	1.42e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.5e-07	1.37e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTEN—urinary bladder cancer	6.02e-07	1.27e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—EP300—urinary bladder cancer	5.74e-07	1.21e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.32e-07	1.12e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.64e-07	9.79e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.43e-07	9.33e-06	CbGpPWpGaD
